
Patient dosing milestone achieved in phase 2 stroke trial
Western Australian based biotech company Argenica Therapeutics has announced the successful recruitment of the first five patients in the Phase...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Discover our latest videos on the Perron Institute YouTube channel. See the Perron Institute’s appearances in the media here.

Western Australian based biotech company Argenica Therapeutics has announced the successful recruitment of the first five patients in the Phase...

Compassionate Communities Australia (CCAus) was launched by Perron Institute Patron, His Excellency the Honourable Chris Dawson AC APM Governor of...

A recent study by WA researchers provides new insights into the use of static magnetic stimulation (SMS) as a non-invasive...

The Perron Institute recently partnered with the West Australian Marathon Club (WAMC) for the 2024 Perron Institute Bridges Fun Run...

The enormous public health impact of conditions affecting the nervous system is quantified in a global analysis recently published in...

A national, multi-centre research project evaluating a new model of stroke rehabilitation is calling for more volunteers. Western Australia’s Perron...

A new network of Western Australian and international rare disease experts is being formed to develop precision medicines for the...

On 7 April, Channel 9’s Innovation Nation program highlighted Australian innovators included two researchers from the Perron Institute. The ‘NeuroArmor A Breakthrough...

A neuroprotective drug developed in Western Australia has been granted Rare Pediatric Disease Designation (RPDD) by the U.S. Food and...

Being able to help people with multiple sclerosis (MS) and hopefully improve their day is something that inspires Perron Institute...

A total of $4.73 million in funding has been awarded to 25 early and mid-career researchers under the Future Health...

Finding new biological markers for multiple sclerosis (MS) and other diseases remains a goal for Dr Xiaonan Zhong, MD and...
Stay up to date with our latest news and announcements.